Semaglutide Market Size to Reach USD 59.75 Billion by 2033, Experiencing High Demand for an Efficient Treatment for Diabetes and Obesity – SNS Insider
Superior clinical efficacy, expanding regulatory approvals, and rising insurance coverage are accelerating global adoption of semaglutide-based treatments. Austin, Texas, Jan.…